Holocene Advisors’s AstraZeneca AZN Stock Holding History

Holocene Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-791,500	Closed	-$107M	–	703
2023 Q3	$107M	Buy	791,500 +43,500	+6%	+$5.94M	0.47%	65
2023 Q2	$107M	Buy	748,000 +186,600	+33%	+$27.5M	0.46%	75
2023 Q1	$77.9M	Buy	+561,400	New	+$75.5M	0.38%	86
2021 Q3	–	Sell	-306,250	Closed	-$36.7M	–	807
2021 Q2	$36.7M	Buy	+306,250	New	+$33.6M	0.21%	147
2020 Q3	–	Sell	-158,150	Closed	-$16.7M	–	672
2020 Q2	$16.7M	Buy	+158,150	New	+$16.3M	0.15%	163

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Holocene Advisors's AZN Position: Q2 2026 in Review

Holocene Advisors reduced its AstraZeneca (AZN) stake by 8.8% in Q2 2026, selling an estimated $43.9M and leaving 2,429,349 shares worth $461M. The position accounts for 1.04% of the portfolio, ranked #13.

Holocene Advisors first reported a position in AZN in Q2 2019 and has held it in 23 quarters since. The position peaked at $525M in Q1 2026. 1,506 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Holocene Advisors held 2,429,349 shares of AstraZeneca worth $461M as of Q2 2026.
Holocene Advisors sold 233,538 AstraZeneca shares in Q2 2026, an estimated $43.9M.
AstraZeneca made up 1.04% of Holocene Advisors's portfolio in Q2 2026, its #13 holding.
Holocene Advisors first reported a position in AstraZeneca in Q2 2019 and has held it in 23 quarters since.
Holocene Advisors's AstraZeneca position peaked at $525M in Q1 2026.
1,506 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.